Literature DB >> 25635638

Stereotactic radiosurgery for spinal metastases with or without separation surgery.

Berkeley G Bate1, Nickalus R Khan, Brent Y Kimball, Kyle Gabrick, Jason Weaver.   

Abstract

OBJECT: In patients with significant epidural spinal cord compression, initial surgical decompression and stabilization of spinal metastases, as opposed to radical oncological resection, provides a margin around the spinal cord that facilitates subsequent treatment with high-dose adjuvant stereotactic radiosurgery (SRS). If a safe margin exists between tumor and spinal cord on initial imaging, then high-dose SRS may be used as the primary therapy, eliminating the need for surgery. Selecting the appropriate approach has shown greater efficacy of tumor control, neurological outcome, and duration of response when compared with external beam radiotherapy, regardless of tumor histology. This study evaluates the efficacy of this treatment approach in a series of 57 consecutive patients.
METHODS: Patients treated for spinal metastases between 2007 and 2011 using the Varian Trilogy Linear Accelerator were identified retrospectively. Each received SRS, with or without initial surgical decompression and instrumentation. Medical records were reviewed to assess neurological outcome and surgical or radiation-induced complications. Magnetic resonance images were obtained for each patient at 3-month intervals posttreatment, and radiographic response was assessed as stability/regression or progression. End points were neurological outcome and local radiographic disease control at death or latest follow-up.
RESULTS: Fifty-seven patients with 69 lesions were treated with SRS for spinal metastases. Forty-eight cases (70%) were treated with SRS alone, and 21 (30%) were treated with surgery prior to SRS. A single fraction was delivered in 38 cases (55%), while a hypofractionated scheme was used in 31 (45%). The most common histological entities were renal cell, breast, and lung carcinomas. Radiographically, local disease was unchanged or regressed in 63 of 69 tumors (91.3%). Frankel score improved or remained stable in 68 of 69 cases (98.6%).
CONCLUSIONS: SRS, alone or as an adjunct following surgical decompression, provides durable local radiographic disease control while preserving or improving neurological function. This less-invasive alternative to radical spinal oncological resection appears to be effective regardless of tumor histology without sacrificing durability of radiographic or clinical response.

Entities:  

Keywords:  CTV = clinical tumor volume; ESCC = epidural spinal cord compression; GTV = gross tumor volume; SRS = stereotactic radiosurgery; cEBRT = conventional external beam radiation therapy; decompression; hypofractionated; instrumentation; local control; metastases; metastasis; oncology; radiosurgery; separation surgery; single fraction; spine

Mesh:

Year:  2015        PMID: 25635638     DOI: 10.3171/2014.10.SPINE14252

Source DB:  PubMed          Journal:  J Neurosurg Spine        ISSN: 1547-5646


  31 in total

1.  Safety and utility of kyphoplasty prior to spine stereotactic radiosurgery for metastatic tumors: a clinical and dosimetric analysis.

Authors:  Ori Barzilai; Natalie DiStefano; Eric Lis; Yoshiya Yamada; D Michael Lovelock; Andrew N Fontanella; Mark H Bilsky; Ilya Laufer
Journal:  J Neurosurg Spine       Date:  2017-11-03

2.  The impact of histology and delivered dose on local control of spinal metastases treated with stereotactic radiosurgery.

Authors:  Yoshiya Yamada; Evangelia Katsoulakis; Ilya Laufer; Michael Lovelock; Ori Barzilai; Lily A McLaughlin; Zhigang Zhang; Adam M Schmitt; Daniel S Higginson; Eric Lis; Michael J Zelefsky; James Mechalakos; Mark H Bilsky
Journal:  Neurosurg Focus       Date:  2017-01       Impact factor: 4.047

3.  Spine metastases: are minimally invasive surgical techniques living up to the hype?

Authors:  Fahed Zairi; Marie-Helene Vieillard; Richard Assaker
Journal:  CNS Oncol       Date:  2015-06-22

4.  Emergency Neurologic Life Support: Spinal Cord Compression.

Authors:  Kristine H O'Phelan
Journal:  Neurocrit Care       Date:  2017-09       Impact factor: 3.210

5.  The era of stereotactic body radiotherapy for spinal metastases and the multidisciplinary management of complex cases.

Authors:  Rachit Kumar; Anick Nater; Ahmed Hashmi; Sten Myrehaug; Young Lee; Lijun Ma; Kristin Redmond; Simon S Lo; Eric L Chang; Albert Yee; Charles G Fisher; Michael G Fehlings; Arjun Sahgal
Journal:  Neurooncol Pract       Date:  2015-07-27

6.  Consensus Contouring Guidelines for Postoperative Stereotactic Body Radiation Therapy for Metastatic Solid Tumor Malignancies to the Spine.

Authors:  Kristin J Redmond; Scott Robertson; Simon S Lo; Scott G Soltys; Samuel Ryu; Todd McNutt; Samuel T Chao; Yoshiya Yamada; Amol Ghia; Eric L Chang; Jason Sheehan; Arjun Sahgal
Journal:  Int J Radiat Oncol Biol Phys       Date:  2016-09-17       Impact factor: 7.038

7.  The Metastatic Spine Disease Multidisciplinary Working Group Algorithms.

Authors:  Adam N Wallace; Clifford G Robinson; Jeffrey Meyer; Nam D Tran; Afshin Gangi; Matthew R Callstrom; Samuel T Chao; Brian A Van Tine; Jonathan M Morris; Brian M Bruel; Jeremiah Long; Robert D Timmerman; Jacob M Buchowski; Jack W Jennings
Journal:  Oncologist       Date:  2015-09-09

8.  Consensus guidelines for postoperative stereotactic body radiation therapy for spinal metastases: results of an international survey.

Authors:  Kristin J Redmond; Simon S Lo; Scott G Soltys; Yoshiya Yamada; Igor J Barani; Paul D Brown; Eric L Chang; Peter C Gerszten; Samuel T Chao; Robert J Amdur; Antonio A F De Salles; Matthias Guckenberger; Bin S Teh; Jason Sheehan; Charles R Kersh; Michael G Fehlings; Moon-Jun Sohn; Ung-Kyu Chang; Samuel Ryu; Iris C Gibbs; Arjun Sahgal
Journal:  J Neurosurg Spine       Date:  2016-11-11

Review 9.  Diagnostic and Therapeutic Strategies for Patients with Malignant Epidural Spinal Cord Compression.

Authors:  Dilan A Patel; Jian L Campian
Journal:  Curr Treat Options Oncol       Date:  2017-08-10

10.  Survival Trends After Surgery for Spinal Metastatic Tumors: 20-Year Cancer Center Experience.

Authors:  Robert J Rothrock; Ori Barzilai; Anne S Reiner; Eric Lis; Adam M Schmitt; Daniel S Higginson; Yoshiya Yamada; Mark H Bilsky; Ilya Laufer
Journal:  Neurosurgery       Date:  2021-01-13       Impact factor: 4.654

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.